Get started
ACTICOR BIOTECHAA

ACTICOR BIOTECH

0.17EURR
−0.06−27.35%
Last update at Dec 10, 2024, 07:00 GMT
EUR
No trades
See on Supercharts
Overview
Financials
Discussions Technicals Seasonals

7V7 fundamentals

Key facts

Market capitalization‪3.94 M‬EUR
Dividend yield (indicated)—
Price to earnings Ratio (TTM)—
Basic EPS (TTM)−1.14EUR
Founded2013
Employees (FY)28
CEOGilles Avenard
Websiteacticor-biotech.com
About

Acticor Biotech SAS engages in the research and development of an antithrombotic agent for the treatment of the acute thrombotic diseases. It specializes on ischemic stroke. The company was founded on November 26, 2013 and is headquartered in Paris, France.

Ownership
‪‪15.76 M‬‬
Closely held shares
‪‪9.00 M‬‬ (57.13%)
Free Float shares
‪‪6.75 M‬‬ (42.87%)
Closely held shares
‪‪9.00 M‬‬ (57.13%)
Free Float shares
‪‪6.75 M‬‬ (42.87%)
Capital structure
Market cap
‪‪3.94 M‬‬
Debt
‪‪7.25 M‬‬
Cash & equivalents
‪‪4.82 M‬‬
Enterprise value
‪‪6.37 M‬‬

Valuation

Fundamental metrics to determine fair value of the stock

Summary
‪‪3.94 M‬‬
Price to earning ratio (P/E)
—
Price to sales ratio (P/S)
—
Market Cap
Net income
Revenue
Price to earning ratio (P/E)
—
Price to sales ratio (P/S)
—
Valuation ratios
H1 '22
H2 '22
H1 '23
H2 '23
H1 '24

Growth and Profitability

Company’s recent performance and margins

Performance
H1 '22
H2 '22
H1 '23
H2 '23
H1 '24
‪‪−10.40 M‬‬
‪‪−7.80 M‬‬
‪‪−5.20 M‬‬
‪‪−2.60 M‬‬
‪0.00‬
Revenue
Net income
Net margin %
Revenue to profit conversion
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
‪‪−8.00 M‬‬
‪‪−6.00 M‬‬
‪‪−4.00 M‬‬
‪‪−2.00 M‬‬
‪0.00‬
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
‪‪−8.00 M‬‬
‪‪−6.00 M‬‬
‪‪−4.00 M‬‬
‪‪−2.00 M‬‬
‪0.00‬

Estimates

Revenue and Earnings forecasts and estimates accuracy

Revenue
2021
2022
2023
2025
‪0.00‬
Actual
Estimate
Earnings
Next:Sep 3, 2025
H1 '23
H2 '23
H1 '24
H2 '24
‪−1.00‬
‪−0.75‬
‪−0.50‬
‪−0.25‬
‪0.00‬
Actual

Dividends

Dividend yield, history and sustainability

7V7 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company

Debt level and coverage
H1 '22
H2 '22
H1 '23
H2 '23
H1 '24
‪‪−8.00 M‬‬
‪‪−4.00 M‬‬
‪0.00‬
‪‪4.00 M‬‬
‪‪8.00 M‬‬
Debt
Free cash flow
Cash & equivalents
Financial position analysis
Short term
Long term
‪0.00‬
‪‪3.00 M‬‬
‪‪6.00 M‬‬
‪‪9.00 M‬‬
‪‪12.00 M‬‬
Assets
Liabilities